Investors Can Join Class Action Against ADMA Biologics for Securities Fraud Allegations

Class Action Lawsuit Overview

The Schall Law Firm, a prominent national firm specializing in protecting shareholder rights, has made a significant announcement for investors affected by alleged misconduct at ADMA Biologics, Inc. This company, publicly traded on NASDAQ under the ticker symbol ADMA, faces serious allegations that could provide a path for investors to recover losses.

The lawsuit pertains specifically to periods when the company is accused of violating several important provisions of the Securities Exchange Act of 1934. Key allegations against ADMA include providing misleading information and failing to disclose critical financial data that influenced stock prices. The class action is open to shareholders who purchased ADMA's securities between August 9, 2024, and March 25, 2026. Those who endured financial losses during this timeframe are urged to consider joining the lawsuit to seek compensatory damages.

Allegations Against ADMA Biologics

According to the lawsuit, ADMA is accused of multiple wrongdoings:
1. False Representations: The complaint highlights that ADMA released information to the market that was deemed false and misleading. Investors were led to believe the company's financial health was significantly better than it actually was.
2. Undisclosed Transactions: The lawsuit singles out a related party transaction that was reportedly not disclosed to shareholders, which raises significant ethical concerns under securities laws.
3. Revenue Manipulation: The complaint indicates that the company engaged in 'channel stuffing', a practice where sales are exaggerated to inflate revenue figures, thus painting a misleading picture of actual company performance.
4. Failure of Internal Controls: It is alleged that ADMA did not maintain adequate internal controls, leading to an environment where misleading statements could be made and sustained without immediate recourse.

When the market eventually recognized the truth regarding ADMA's financial position, the stock price fell considerably, resulting in financial damages for the investors.

Next Steps for Concerned Investors

Investors who believe they are part of the affected group are strongly encouraged to reach out to the Schall Law Firm. The firm is offering free consultations, allowing investors to discuss their individual cases and rights without immediate financial commitment. Brian Schall, a leading attorney at the firm, noted that these types of class actions are crucial in holding companies accountable for their actions and ensuring that investors can recover what they rightfully deserve.

To take part in the lawsuit, interested investors can contact the Schall Law Firm directly at their Los Angeles office or via their official website. However, they should be mindful of the timeline, as the opportunity to join the class will close on August 10, 2026.

Conclusion

This situation serves as a reminder of the importance of transparency in financial markets and the vital role that Class Action lawsuits play in maintaining corporate accountability. Investors who feel misled by ADMA's business practices should act promptly to protect their interests and potentially recover their losses.